IL2 and melanoma: However, in our study, we showed that inhibition of IFN-γ secretion itself could also contribute to abnormal STAT1 activation in melanoma patients, because STAT1 was not directly phosphorylated by IL-2 signaling, but depended on IFN-γ released by NK and T lymphocytes when stimulated with IL-2.